Dr. Holmes is interviewed by Desert Health News reporter/publisher who discusses her own experience

The COVID-19 pandemic has placed a tremendous burden on the healthcare system, resulting in the postponement of elective surgical procedures to preserve limited hospital resources and minimize viral transmission.

While no one is immune to the COVID-19 virus or the collateral damage that it has caused, breast cancer patient may be particularly concerned about the impact of this crisis on their efforts to maintain their breast and overall health.

Dr. Holmes point of view on the JAMA Oncology editorial that discusses advantages and disadvantages of de-escalating breast cancer surgery.

Read Dr. Holmes response to a cryoablation article where a surgeon in Palm Springs, CA received probation for offering cryoablation as an alternative to surgery for early stage breast cancer.

It is with great pleasure that I announce the publication of the long-term results of the TARGIT-A Trial, a clinical trial that compared partial breast single dose targeted intraoperative radiotherapy (IORT) to 3-6 week post-operative whole breast...

In the first edition of this guide, the world was just getting a handle on the impact that Coronavirus (COVID-19) would have on our daily lives. Things are quite a bit more clear now. For far too many in the U.S., the impact has been monumental...